Selected research
Industry Research
Porcine Medicine and Vaccines Industry Research Report 2026
Market perspective
The global Porcine Medicine and Vaccines market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Porcine Medicine and Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Porcine Medicine and Vaccines market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Porcine Medicine and Vaccines market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Porcine Medicine and Vaccines include Merck, Jinyu Bio-Technology, ChengDu Tecbond, Zoetis, WINSUN, Virbac, Tecon, Ringpu Biology and HVRI, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Porcine Medicine and Vaccines market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Porcine Medicine and Vaccines.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Porcine Medicine and Vaccines Market by Company
Merck
Jinyu Bio-Technology
ChengDu Tecbond
Zoetis
WINSUN
Virbac
Tecon
Ringpu Biology
HVRI
Hipra
Hile Bio
DHN
Chopper Biology
Ceva
CAVAC
CAHIC
Boehringer Ingelheim
Bioveta
Porcine Medicine and Vaccines Segment by Type
Medicine
Vaccines
Porcine Medicine and Vaccines Segment by Application
Government Tender
Market Sales
Porcine Medicine and Vaccines Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Porcine Medicine and Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Porcine Medicine and Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Porcine Medicine and Vaccines.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Porcine Medicine and Vaccines companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Medicine
- Vaccines
Applications
- Government Tender
- Market Sales
Companies covered
- Merck
- Jinyu Bio-Technology
- ChengDu Tecbond
- Zoetis
- WINSUN
- Virbac
- Tecon
- Ringpu Biology
- HVRI
- Hipra
- Hile Bio
- DHN
- Chopper Biology
- Ceva
- CAVAC
- CAHIC
- Boehringer Ingelheim
- Bioveta
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Porcine Medicine and Vaccines by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Medicine
- 2.2.3 Vaccines
- 2.3 Porcine Medicine and Vaccines by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Government Tender
- 2.3.3 Market Sales
- 2.4 Assumptions and Limitations
3 Porcine Medicine and Vaccines Breakdown Data by Type
- 3.1 Global Porcine Medicine and Vaccines Historic Market Size by Type (2021-2026)
- 3.2 Global Porcine Medicine and Vaccines Forecasted Market Size by Type (2027-2032)
4 Porcine Medicine and Vaccines Breakdown Data by Application
- 4.1 Global Porcine Medicine and Vaccines Historic Market Size by Application (2021-2026)
- 4.2 Global Porcine Medicine and Vaccines Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Porcine Medicine and Vaccines Market Perspective (2021-2032)
- 5.2 Global Porcine Medicine and Vaccines Growth Trends by Region
- 5.2.1 Global Porcine Medicine and Vaccines Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Porcine Medicine and Vaccines Historic Market Size by Region (2021-2026)
- 5.2.3 Porcine Medicine and Vaccines Forecasted Market Size by Region (2027-2032)
- 5.3 Porcine Medicine and Vaccines Market Dynamics
- 5.3.1 Porcine Medicine and Vaccines Industry Trends
- 5.3.2 Porcine Medicine and Vaccines Market Drivers
- 5.3.3 Porcine Medicine and Vaccines Market Challenges
- 5.3.4 Porcine Medicine and Vaccines Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Porcine Medicine and Vaccines Players by Revenue
- 6.1.1 Global Top Porcine Medicine and Vaccines Players by Revenue (2021-2026)
- 6.1.2 Global Porcine Medicine and Vaccines Revenue Market Share by Players (2021-2026)
- 6.2 Global Porcine Medicine and Vaccines Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Porcine Medicine and Vaccines Head Office and Area Served
- 6.4 Global Porcine Medicine and Vaccines Players, Product Type & Application
- 6.5 Global Porcine Medicine and Vaccines Manufacturers Established Date
- 6.6 Global Porcine Medicine and Vaccines Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Porcine Medicine and Vaccines Market Size (2021-2032)
- 7.2 North America Porcine Medicine and Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Porcine Medicine and Vaccines Market Size by Country (2021-2026)
- 7.4 North America Porcine Medicine and Vaccines Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Porcine Medicine and Vaccines Market Size (2021-2032)
- 8.2 Europe Porcine Medicine and Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Porcine Medicine and Vaccines Market Size by Country (2021-2026)
- 8.4 Europe Porcine Medicine and Vaccines Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Porcine Medicine and Vaccines Market Size (2021-2032)
- 9.2 Asia-Pacific Porcine Medicine and Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Porcine Medicine and Vaccines Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Porcine Medicine and Vaccines Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Porcine Medicine and Vaccines Market Size (2021-2032)
- 10.2 South America Porcine Medicine and Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Porcine Medicine and Vaccines Market Size by Country (2021-2026)
- 10.4 South America Porcine Medicine and Vaccines Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Porcine Medicine and Vaccines Market Size (2021-2032)
- 11.2 Middle East & Africa Porcine Medicine and Vaccines Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Porcine Medicine and Vaccines Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Porcine Medicine and Vaccines Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Merck
- 12.1.1 Merck Company Information
- 12.1.2 Merck Business Overview
- 12.1.3 Merck Revenue in Porcine Medicine and Vaccines Business (2021-2026)
- 12.1.4 Merck Porcine Medicine and Vaccines Product Portfolio
- 12.1.5 Merck Recent Developments
- 12.2 Jinyu Bio-Technology
- 12.2.1 Jinyu Bio-Technology Company Information
- 12.2.2 Jinyu Bio-Technology Business Overview
- 12.2.3 Jinyu Bio-Technology Revenue in Porcine Medicine and Vaccines Business (2021-2026)
- 12.2.4 Jinyu Bio-Technology Porcine Medicine and Vaccines Product Portfolio
- 12.2.5 Jinyu Bio-Technology Recent Developments
- 12.3 ChengDu Tecbond
- 12.3.1 ChengDu Tecbond Company Information
- 12.3.2 ChengDu Tecbond Business Overview
- 12.3.3 ChengDu Tecbond Revenue in Porcine Medicine and Vaccines Business (2021-2026)
- 12.3.4 ChengDu Tecbond Porcine Medicine and Vaccines Product Portfolio
- 12.3.5 ChengDu Tecbond Recent Developments
- 12.4 Zoetis
- 12.4.1 Zoetis Company Information
- 12.4.2 Zoetis Business Overview
- 12.4.3 Zoetis Revenue in Porcine Medicine and Vaccines Business (2021-2026)
- 12.4.4 Zoetis Porcine Medicine and Vaccines Product Portfolio
- 12.4.5 Zoetis Recent Developments
- 12.5 WINSUN
- 12.5.1 WINSUN Company Information
- 12.5.2 WINSUN Business Overview
- 12.5.3 WINSUN Revenue in Porcine Medicine and Vaccines Business (2021-2026)
- 12.5.4 WINSUN Porcine Medicine and Vaccines Product Portfolio
- 12.5.5 WINSUN Recent Developments
- 12.6 Virbac
- 12.6.1 Virbac Company Information
- 12.6.2 Virbac Business Overview
- 12.6.3 Virbac Revenue in Porcine Medicine and Vaccines Business (2021-2026)
- 12.6.4 Virbac Porcine Medicine and Vaccines Product Portfolio
- 12.6.5 Virbac Recent Developments
- 12.7 Tecon
- 12.7.1 Tecon Company Information
- 12.7.2 Tecon Business Overview
- 12.7.3 Tecon Revenue in Porcine Medicine and Vaccines Business (2021-2026)
- 12.7.4 Tecon Porcine Medicine and Vaccines Product Portfolio
- 12.7.5 Tecon Recent Developments
- 12.8 Ringpu Biology
- 12.8.1 Ringpu Biology Company Information
- 12.8.2 Ringpu Biology Business Overview
- 12.8.3 Ringpu Biology Revenue in Porcine Medicine and Vaccines Business (2021-2026)
- 12.8.4 Ringpu Biology Porcine Medicine and Vaccines Product Portfolio
- 12.8.5 Ringpu Biology Recent Developments
- 12.9 HVRI
- 12.9.1 HVRI Company Information
- 12.9.2 HVRI Business Overview
- 12.9.3 HVRI Revenue in Porcine Medicine and Vaccines Business (2021-2026)
- 12.9.4 HVRI Porcine Medicine and Vaccines Product Portfolio
- 12.9.5 HVRI Recent Developments
- 12.10 Hipra
- 12.10.1 Hipra Company Information
- 12.10.2 Hipra Business Overview
- 12.10.3 Hipra Revenue in Porcine Medicine and Vaccines Business (2021-2026)
- 12.10.4 Hipra Porcine Medicine and Vaccines Product Portfolio
- 12.10.5 Hipra Recent Developments
- 12.11 Hile Bio
- 12.11.1 Hile Bio Company Information
- 12.11.2 Hile Bio Business Overview
- 12.11.3 Hile Bio Revenue in Porcine Medicine and Vaccines Business (2021-2026)
- 12.11.4 Hile Bio Porcine Medicine and Vaccines Product Portfolio
- 12.11.5 Hile Bio Recent Developments
- 12.12 DHN
- 12.12.1 DHN Company Information
- 12.12.2 DHN Business Overview
- 12.12.3 DHN Revenue in Porcine Medicine and Vaccines Business (2021-2026)
- 12.12.4 DHN Porcine Medicine and Vaccines Product Portfolio
- 12.12.5 DHN Recent Developments
- 12.13 Chopper Biology
- 12.13.1 Chopper Biology Company Information
- 12.13.2 Chopper Biology Business Overview
- 12.13.3 Chopper Biology Revenue in Porcine Medicine and Vaccines Business (2021-2026)
- 12.13.4 Chopper Biology Porcine Medicine and Vaccines Product Portfolio
- 12.13.5 Chopper Biology Recent Developments
- 12.14 Ceva
- 12.14.1 Ceva Company Information
- 12.14.2 Ceva Business Overview
- 12.14.3 Ceva Revenue in Porcine Medicine and Vaccines Business (2021-2026)
- 12.14.4 Ceva Porcine Medicine and Vaccines Product Portfolio
- 12.14.5 Ceva Recent Developments
- 12.15 CAVAC
- 12.15.1 CAVAC Company Information
- 12.15.2 CAVAC Business Overview
- 12.15.3 CAVAC Revenue in Porcine Medicine and Vaccines Business (2021-2026)
- 12.15.4 CAVAC Porcine Medicine and Vaccines Product Portfolio
- 12.15.5 CAVAC Recent Developments
- 12.16 CAHIC
- 12.16.1 CAHIC Company Information
- 12.16.2 CAHIC Business Overview
- 12.16.3 CAHIC Revenue in Porcine Medicine and Vaccines Business (2021-2026)
- 12.16.4 CAHIC Porcine Medicine and Vaccines Product Portfolio
- 12.16.5 CAHIC Recent Developments
- 12.17 Boehringer Ingelheim
- 12.17.1 Boehringer Ingelheim Company Information
- 12.17.2 Boehringer Ingelheim Business Overview
- 12.17.3 Boehringer Ingelheim Revenue in Porcine Medicine and Vaccines Business (2021-2026)
- 12.17.4 Boehringer Ingelheim Porcine Medicine and Vaccines Product Portfolio
- 12.17.5 Boehringer Ingelheim Recent Developments
- 12.18 Bioveta
- 12.18.1 Bioveta Company Information
- 12.18.2 Bioveta Business Overview
- 12.18.3 Bioveta Revenue in Porcine Medicine and Vaccines Business (2021-2026)
- 12.18.4 Bioveta Porcine Medicine and Vaccines Product Portfolio
- 12.18.5 Bioveta Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst